Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients

Anticancer Research

Volumn 29, Issue 9, 2009, Pages 3669-3674

  Nurnberg B ^a   Graber S ^a   Gartner B ^a   Geisel, J ^a   Pfohler C ^a   Schadendorf, D ^b   Tilgen, W ^a   Reichrath, Jörg ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

25 hydroxyvitamin D levels; Malignant melanoma; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; CANCER PATIENT; CONFERENCE PAPER; CONTROLLED STUDY; DISTANT METASTASIS; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; TUMOR VOLUME; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SEASONS; SKIN NEOPLASMS; SUNLIGHT; VITAMIN D; YOUNG ADULT;

EID: 68549087029     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. 3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res 51: 1227-1233, 1991.
2. 3 receptors in normal and malignant human colorectal tissues. Cancer Lett 86: 67-73, 1994. (Pubitemid 24318984)
3. Zehnder D, Bland R, Williams MC et al: Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001. (Pubitemid 32207511)
4. 3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium. Cancer Lett 97: 99-106, 1995.
5. 3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 60: 2304-2312, 2000. (Pubitemid 30225198)
6. Kip1, Endocrinology 141: 3931-3939, 2000.
7. 3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J Cancer 81: 730-733, 1999. (Pubitemid 29214382)
8. 3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 24: 6533-6544, 2005. (Pubitemid 41486636)
9. Lamprecht SA and Lipkin M: Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci 952: 73-87, 2001.
10. 3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model. Int J Oncol 16: 1249-1254, 2000.
11. Garland CF, Comstock GW, Garland FC et al: Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176-1178, 1989. (Pubitemid 19275448)
12. Braun MM, Helzlsouer KJ, Hollis BW et al: Colon cancef and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 142: 608-611, 1995.
13. Tangrea J, Helzlsouer K, Pietinen P et al: Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8: 615-625, 1997. (Pubitemid 27330494)
14. Feskanich D, Ma J, Fuchs CS et al: Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13: 1502-1508, 2004. (Pubitemid 39202318)
15. Wactawski-Wende J, Kotchen JM, Anderson GL et al: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354: 684-696, 2006. (Pubitemid 43247139)
16. Wu K, Feskanich D, Fuchs CS et al: A nested case-control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 99: 1120-1129, 2007. (Pubitemid 47241396)
17. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Giovannucci E, Su L and Christiani DC: Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small cell lung cancer patients. J Clin Oncol 25(34): 479-485, 2007 (Pubitemid 350002952)
18. Goodwin PJ, Ennis M, Pritchard KI, Koo J and Hood N: Frequency of vitamin D (Vit. D) deficiency at breast cancer (BC) diagnosis and association with risk of distant recurrence and death in a prospective cohort study of T1-3, N0-1, M0 BC. J Clin Oncol 26: (May 20 suppl; abstr 511), 2008.
19. Ng K, Meyerhardt JA, Wu K, Faskanich D, Hollis BW, Giovannucci EL and Fuchs CS: Circulating 25-hydrdxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26(18): 2937-2939, 2008.
20. Gorham ED, Garland CF, Garland FC et al: Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32: 210-216, 2007.
21. Lappe JM, Travers-Gustafson D, Davies KM et al: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591, 2007. (Pubitemid 46890428)
22. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 69: 842-856, 1999. (Pubitemid 29205056)
23. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-282, 2007.
24. Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C and Barnhill R: Sun exposure and mortality from melanoma. J Natl Cancer Inst 97(3): 195-199, 2005.
25. Berwick M, Lachiewicz A, Pestak C and Thomas N: Solar UV exposure and mortality from skin tumors. Adv Exp Med Biol 624: 117-124, 2008.
26. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P et al: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41(1): 45-60, 2005. (Pubitemid 40029658)
27. Nelemans PJ, Groenendal H, Kiemeney LA, Rampen FH, Ruiter DJ and Verbeek AL: Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 101(3): 252-255, 1993.
28. Rosso S, Sera F, Segnan N and Zanetti R: Sun exposure prior to diagnosis is associated with improved survival in melanoma patients: results from a long-term follow-up study of Italian patients. Eur J Can 44(9): 1275-1281, 2008.
29. Lips P: Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90: 611-614, 2004.
30. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ and Vieth R: Estimates of optimal vitamin D status. Osteoporosis Int 16: 713-716, 2005.
31. Aloia JF, Talwar SA, Pollack S, Feuermann M and Yeh JW: Optimal vitamin D status and serum parathyroid hormone concentration in African American women. Am J Clin Nutr 84: 602-609, 2006. (Pubitemid 44713411)
32. Bischoff-Ferrari HA, Giovannucci E, Willet WC, Dietrich T and Dawson-Hughes B: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18-28, 2006. (Pubitemid 44699167)
33. Holick MF: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81: 353-373, 2006. (Pubitemid 43334631)
34. Malabanan A, Veronikis IE and Holick MF: Redefining vitamin D insufficiency. Lancet 351: 805-806, 1998.
35. Thomas KK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL and Finkelstein JS: Hypovitaminosis D in medical inpatients. N Engl J Med 338: 777-783, 1998.
36. Hintzpeter B, Mensink GBM, Thierfelder W, Müller MJ and Scheidt-Nave C: Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62(9): 1079-1089, 2008.
37. Need AG, Morris HA, Horowitz M and Nordin C: Effects of the skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr 58: 882-885, 1993. (Pubitemid 23353596)
38. Jaques PF, Felson DT, Tucker KL, Mahnken B, Wilson PWF and Rosenberg IH: Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr 66: 929-936, 1997. (Pubitemid 27415579)
39. Snijder MB, van Schoor NM, Pluijm SM, van Damm RM, Visser M and Lips P: Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91: 2980-2985, 2006. (Pubitemid 44271745)
40. Konradsen S, Ag H, Lindberg F, Hexeberg S and Jorde R: Serum 1,25-dihydroxyvitamin D is inversely associated with body mass index. Eur J Nutr 47(2): 87-91, 2008.
41. Wortsman K, Matsuoka LY, Chen TC, Lu Z and Holick MF: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: 690-693, 2000.
42. Reichrath J and Querings K: No evidence for reduced 25-hydroxyvitamin D serum levels in melanoma patients. Cancer Causes Control 15: 97-98, 2004. (Pubitemid 38339978)
43. Cummings SR, Nevitt MC, Browner WS et al: Risk factors for hip fractures in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332(12): 767-773, 1995.
44. Boniol M, Armstrong BK and Doré JF: Variations in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia. Cancer Epidemiol Biomarkers Prev 15(3): 524-526, 2006.
45. Morales Suárez-Varela M, Llopis-González A, Lacasana-Navarro M and Ferrandiz-Ferragud J: Trends in malignant skin melanoma and other skin cancers in Spain, 1975-1983, and their relation to solar radiation intensity. J Environ Pathol Toxicol Oncol 10(4-5): 245-253, 1990.